Please login to the form below

Not currently logged in

Philip Blake appointed senior Bayer rep in the US

Will remain as US head of Bayer Healthcare Pharmaceuticals

Bayer - Philip Blake Bayer has named current US head of Bayer Healthcare Pharmaceuticals Philip Blake as its senior Bayer representative for the US.

Maintaining his current position in the US speciality pharma division of the company, Blake will also assume the role of Bayer Healthcare representative for the US on July 1, 2012.

According to Bayer, it is “common company practice” to assign the role of senior Bayer representative for the US to a senior executive who already holds a significant business role within the region.

Blake, who has been with Bayer for more than 30 years, takes over from Greg Babe who is due to retire.

“Phil Blake is a highly valued and respected leader at Bayer,” said Dr Richard Pott, member of the management board of Bayer AG.

In his combined roles, Blake will continue to oversee the US-based specialty pharmaceuticals division of Bayer Healthcare, a subsidiary of Bayer AG, which includes products covering haematology, neurology and oncology, as well as leading all of Bayer's corporate operations in the US.

Prior to his current role, Blake served as president and CEO of Bayer AG's Canadian subsidiary Bayer Inc and was head of Bayer HealthCare in Canada.

While leading the company's operations in Canada, Bayer became a Canada's Top 100 Employer and a Top Green Employer.

Prior to this he held leadership positions at Bayer around the world, focusing on global strategic product marketing, business development, clinical planning, product developments and sales management.

Other notable achievements for Blake include acting as the chair of the Board of Canada's Research-Based Pharmaceutical Companies – Rx&D, the national association representing the industry in Canada.

In 2006, Blake was inducted into the Canadian Pharmaceutical Marketing Hall of Fame and in 2008 was named Communicator of the Year by the International Association of Business Communicators (IABC).

19th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...